Tectonic Therapeutic, Stock Performance
| TECX Stock | 50.56 3.00 6.31% |
On a scale of 0 to 100, Tectonic Therapeutic, holds a performance score of 17. The entity has a beta of 1.85, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tectonic Therapeutic, will likely underperform. Please check Tectonic Therapeutic,'s potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Tectonic Therapeutic,'s existing price patterns will revert.
Risk-Adjusted Performance
17 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tectonic Therapeutic, are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Tectonic Therapeutic, showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 6.31 | Five Day Return 14.49 | Year To Date Return 192.59 | Ten Year Return (86.50) | All Time Return (86.50) |
Last Split Factor 1:12 | Last Split Date 2024-06-21 |
1 | Acquisition by Springer Timothy A of 300000 shares of Tectonic Therapeutic, at 33.59 subject to Rule 16b-3 | 10/22/2024 |
2 | Thursdays Insider Trading Activity Top Buys and Sells in US Stocks Revealed | 10/25/2024 |
3 | Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights | 11/07/2024 |
4 | Insiders of Tectonic Therapeutic, Inc. were rewarded after last weeks 10 percent gain | 11/12/2024 |
5 | Raymond James sets 65 target on Tectonic Therapeutics shares | 11/19/2024 |
6 | Acquisition by Ruddy Marcella K. of 18704 shares of Tectonic Therapeutic, at 5.38 subject to Rule 16b-3 | 11/25/2024 |
7 | Tectonic Therapeutic To Present on December 3rd, 2024at the Pip | 11/26/2024 |
8 | Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024 | 12/03/2024 |
9 | Acquisition by Reicin Alise of 6000 shares of Tectonic Therapeutic, at 51.28 subject to Rule 16b-3 | 12/04/2024 |
10 | Acquisition by Marc Schwabish of 2000 shares of Tectonic Therapeutic, at 2.38 subject to Rule 16b-3 | 12/09/2024 |
| Begin Period Cash Flow | 36.6 M |
Tectonic |
Tectonic Therapeutic, Relative Risk vs. Return Landscape
If you would invest 2,940 in Tectonic Therapeutic, on September 25, 2024 and sell it today you would earn a total of 2,116 from holding Tectonic Therapeutic, or generate 71.97% return on investment over 90 days. Tectonic Therapeutic, is currently generating 0.9362% in daily expected returns and assumes 4.184% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than Tectonic, and 82% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tectonic Therapeutic, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tectonic Therapeutic,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tectonic Therapeutic,, and traders can use it to determine the average amount a Tectonic Therapeutic,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2238
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TECX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.18 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.94 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Tectonic Therapeutic, is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tectonic Therapeutic, by adding it to a well-diversified portfolio.
Tectonic Therapeutic, Fundamentals Growth
Tectonic Stock prices reflect investors' perceptions of the future prospects and financial health of Tectonic Therapeutic,, and Tectonic Therapeutic, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tectonic Stock performance.
| Current Valuation | 83.39 M | ||||
| Shares Outstanding | 14.73 M | ||||
| Price To Book | 1.59 X | ||||
| EBITDA | (43.17 M) | ||||
| Net Income | (42.82 M) | ||||
| Total Debt | 4.34 M | ||||
| Book Value Per Share | 11.29 X | ||||
| Cash Flow From Operations | (40.68 M) | ||||
| Earnings Per Share | (3.07) X | ||||
| Market Capitalization | 265.07 M | ||||
| Total Asset | 101.09 M | ||||
| Retained Earnings | (477.27 M) | ||||
| Working Capital | 29.2 M | ||||
About Tectonic Therapeutic, Performance
Evaluating Tectonic Therapeutic,'s performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Tectonic Therapeutic, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tectonic Therapeutic, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.42) | (0.44) | |
| Return On Capital Employed | (0.47) | (0.49) | |
| Return On Assets | (0.42) | (0.44) | |
| Return On Equity | (0.45) | (0.47) |
Things to note about Tectonic Therapeutic, performance evaluation
Checking the ongoing alerts about Tectonic Therapeutic, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tectonic Therapeutic, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tectonic Therapeutic, appears to be risky and price may revert if volatility continues | |
| Tectonic Therapeutic, was previously known as AVROBIO and was traded on NASDAQ Exchange under the symbol AVRO. | |
| Net Loss for the year was (42.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tectonic Therapeutic, generates negative cash flow from operations | |
| Tectonic Therapeutic, has a frail financial position based on the latest SEC disclosures | |
| About 39.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Marc Schwabish of 2000 shares of Tectonic Therapeutic, at 2.38 subject to Rule 16b-3 |
- Analyzing Tectonic Therapeutic,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tectonic Therapeutic,'s stock is overvalued or undervalued compared to its peers.
- Examining Tectonic Therapeutic,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tectonic Therapeutic,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tectonic Therapeutic,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tectonic Therapeutic,'s stock. These opinions can provide insight into Tectonic Therapeutic,'s potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Tectonic Stock Analysis
When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.